Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
05/2010
05/26/2010EP2187950A1 Use of insulin c-peptide, alone or in combination with glp-1, as a therapeutic agent
05/26/2010EP2187949A2 Use of glp-1 as a therapeutic agent
05/26/2010EP2187948A2 Use of a peptide as a therapeutic agent
05/26/2010EP2187947A2 Use of calcitonin as anti-angiogenic agent
05/26/2010EP2187946A1 Use of a peptide as a therapeutic agent
05/26/2010EP2187944A1 Use of urodilatin as a therapeutic agent
05/26/2010EP2187942A2 Use of a peptide as a therapeutic agent
05/26/2010EP2187936A1 Minigastrin as a therapeutic agent
05/26/2010EP2187935A2 Use of the peptide his-ser-leu-gly-lys-trp-leu-gly-his-pro-asp-lys-phe alone or in combination with the peptide pro-gly-thr-cys-glu-ile-cys-ala-tyr-ala-ala-cys-thr-gly-cys-oh as a therapeutic agent
05/26/2010EP2187934A1 Use of fertirelin and delta-endorphin as therapeutic agents
05/26/2010EP2187931A2 Use of a combination of cart peptides as a therapeutic agent
05/26/2010EP2187930A2 Trap-14 as a therapeutic agent
05/26/2010EP2187929A2 Use of a peptide as a therapeutic agent
05/26/2010EP2187927A1 Use of the peptide his-ser-leu-gly-lys-trp-leu-gly-his-pro-asp-lys-phe alone or in combination with the peptide gly-ard-gly-asp-asn-pro-oh as a therapeutic agent
05/26/2010EP2187925A1 Use of human neuropeptide as a therapeutic agent
05/26/2010EP2187924A2 Use of a peptide as a therapeutic agent
05/26/2010EP2187922A2 Use of a deslorelin and mastoparan as a therapeutic agent
05/26/2010EP2187921A2 Use of gonadorelin as a therapeutic agent
05/26/2010EP2187917A2 Use of neuropeptide sf, alone or in combination with glp-2, as a therapeutic agent
05/26/2010EP2187915A2 Use of the peptide phpfhlfvy (renin inhibitor) as a therapeutic agent
05/26/2010EP2187913A2 Use of the peptide rfmwmr as a therapeutic agent
05/26/2010EP2187912A2 Use of a peptide as a therapeutic agent
05/26/2010EP2187911A1 Use of peptide yy, alone or in combination with glucagon-like peptide, for use in medicine
05/26/2010EP2187909A1 Use of bpp-b as a therapeutic agent
05/26/2010EP2187908A1 Use of the peptide gly-arg-gly-asp-asn-pro as a therapeutic agent
05/26/2010EP2187907A2 Use of tyr-w-mif-1 and urocortin 2 as therapeutic agents
05/26/2010EP2187906A2 Use of a fibrinogen receptor antagonist and/or follicular gonadotropin releasing peptide as a therapeutic agent in the treatment of streptococcus pneumonia infection
05/26/2010EP2187905A2 Use of melanocyte-stimulating hormone release-inhibiting factor as a therapeutic agent in the treatment of pseudomonas aeruginosa infection
05/26/2010EP2187897A1 Composition for preventing virus infection comprising poly-gamma-glutamic acid
05/26/2010EP2187885A1 Dentifrice compositions for treating xerostomia
05/26/2010EP2187883A2 Nitrogen containing bicyclic chemical entities for treating viral infections
05/26/2010EP2029606B1 Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors
05/26/2010EP1651639B1 Benzofuran derivatives and their use in the treatment of microbial infections
05/26/2010EP1613345B1 Compositions and methods involving respiratory syncytial virus subgroup b strain 9320
05/26/2010EP1461325B1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
05/26/2010EP1424998B1 Synthesis and use of reagents for improved dna lipofection and/or slow release prodrug and drug therapies
05/26/2010EP1294371B2 Medium chain fatty acids applicable as antimicrobial agents
05/26/2010EP1082875B1 Improved brush block housing for propeller deicing system
05/26/2010CN1974598B Isolated proteins from a traditional Chinese medicine yuzhu and use thereof
05/26/2010CN1960736B Anti-infectious hydrogel compositions
05/26/2010CN1956961B Stable crystal form of 4-oxoquinoline compound
05/26/2010CN1951494B Compound Chinese medicinal preparation for treating affection of external wind and cold and preparation method thereof
05/26/2010CN1930180B L-saccharide glucose lipid A analogue
05/26/2010CN1910153B Derivatives of pyridine and quinoline
05/26/2010CN1909894B Pharmaceutical composition
05/26/2010CN1899370B Compound calyx melo extract tablet
05/26/2010CN1880457B Ad6 recombinant nucleic acid
05/26/2010CN1879745B A veterinary Chinese medicinal powder for treating avian viral disease
05/26/2010CN1849117B Entry inhibitors of the HIV virus
05/26/2010CN1838967B Stabilized immunogenic HBc chimer particles
05/26/2010CN1833027B Methods of generating chimeric adenoviruses and uses for such chimeric adenoviruses
05/26/2010CN1832751B Periodontal disease therapeutic and/or preventive composition
05/26/2010CN1799557B Chinese medicinal gel formulation, its preparation process and quality control method
05/26/2010CN1764468B Skin protecting composition
05/26/2010CN1761669B Preparation of a trans-calanolide ketone intermediate
05/26/2010CN1751064B Hsp60 from arthrobacter
05/26/2010CN1746298B Artificial recombinant H7 subinfluenza virus and use thereof
05/26/2010CN1733296B Stable liquid interferon formulations
05/26/2010CN1711279B Epstein Barr virus peptide epitopes, polyepitopes and delivery system therefor
05/26/2010CN1681811B Azolidinone-vinyl fused-benzene derivatives
05/26/2010CN1671412B Immunostimulatory compositions and methods of stimulating an immune response
05/26/2010CN1671380B Broadspectrum 2-amino-benzothiazole sulfonamide HIV protease inhibitors
05/26/2010CN1668637B Molecular antigen arrays using a virus like particle derived from the AP205 coat protein
05/26/2010CN1649883B Bicyclic 6-alkylidene-penems as lactamases inhibitors
05/26/2010CN1646138B Novel therapeutical use of agonist ligands specific to G2A receptor
05/26/2010CN1646124B Use of materials having zinc ionophoric behavior
05/26/2010CN1642580B Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands
05/26/2010CN1604795B Combination motif immune stimulatory oligonucleotides with improved activity
05/26/2010CN1549716B 3-substituted 6,7-dihydroxytetrahydroisoquinoline derivatives for use as antibacterial agents
05/26/2010CN1496270B Pharmaceutical composition based on macrolides for topical application in ophthalmology
05/26/2010CN1489580B 咪唑衍生物 Imidazole derivatives
05/26/2010CN101715455A Antibacterial 1,4,5-substituted aminoglycoside analogs
05/26/2010CN101715451A Novel pyridopyrazine derivatives, process of manufacturing and uses thereof
05/26/2010CN101715349A therapeutic compositions and methods for treating gram-negative bacterial infections
05/26/2010CN101715343A Drug for treatment of influenza
05/26/2010CN101712965A Japanese encephalitis virus JEV replicon vector and application thereof
05/26/2010CN101712949A Gm-negative ehv-mutants without heterologous elements
05/26/2010CN101712935A Candida albicans toxicity related gene CaMSS11 and application thereof
05/26/2010CN101712721A T cell receptor fusions and conjugates and methods of use thereof
05/26/2010CN101712720A Human antibodies that bind human TNF alpha
05/26/2010CN101712719A Preparation method and application of humanized neutralized anti-influenza NS1 genetic engineering antibody
05/26/2010CN101712717A Novel small-molecule polypeptide blocking hepatitis B virus infection
05/26/2010CN101712707A Three crystal-form substances of roxithromycin, preparation method, pharmaceutical composition and application thereof
05/26/2010CN101712692A Medicinal acid addition salt of tenofovir disoproxil fumarate and preparation method and medicinal application thereof
05/26/2010CN101712689A Azepine condensed ring substituted cephalosporin derivative
05/26/2010CN101712688A Hybrid QA molecules wherein Q is an aminoquinoline and A is an antibiotic residue, their synthesis and their uses as antibacterial agent
05/26/2010CN101712686A Method for separating and purifying tacrolimus in fermentation liquor
05/26/2010CN101712679A Acylamide class compound, medicine composition, preparation method and application thereof
05/26/2010CN101712669A Method for separating and purifying luteolin
05/26/2010CN101712660A Derivatives of piperidinyl- and piperazinyl-alkyl carbamates, preparation methods thereof and application of same in therapeutics
05/26/2010CN101712633A Alpha or beta-aldehyde ketone derivative, method for preparing same and activities thereof for resisting drug-resistance bacterium pathogens and helicobacter pylori
05/26/2010CN101712632A Substituted tetracycline compounds
05/26/2010CN101712631A Derivates of rupestonic acid and uses thereof
05/26/2010CN101712594A 2-cyclohexyl-5-(1,1- dimethyl octyl) phenol and synthesizing method thereof
05/26/2010CN101711878A Application of ssrA of staphylococcus aureus in preventing and treating staphylococcus aureus infection
05/26/2010CN101711864A gm-negative ehv-mutants without heterologous elements
05/26/2010CN101711861A bacterial virulence factors and uses thereof
05/26/2010CN101711859A Application of Hfq protein of staphylococcus aureus in preventing and treating staphylococcus aureus infection
05/26/2010CN101711856A Oral liquid for cold
05/26/2010CN101711831A Pediatric Chinese medicinal oral liquid for preventing and treating H1N1 virus and preparation method thereof
1 ... 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 ... 1798